Aryloxazole, aryloxadiazole and benzimidazole derivatives as modulators of somatostatins receptor activity

Details for Australian Patent Application No. 2008258686 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Christ, Andreas D.; Mohr, Peter; Martin, Rainer E.

Agent Spruson & Ferguson

Pub. Number AU-A-2008258686

PCT Pub. Number WO2008/148710

Priority 07109846.1 08.06.07 EP

Filing date 30 May 2008

Wipo publication date 11 December 2008

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2008/148710 Priority application(s): WO2008/148710

27 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008258705-Capsule system, device and method for preparing a food liquid contained in a receptacle by centrifugation

2008258678-Disposable humidifier for use with tobacco products